CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	12 Months Ended
	Dec. 31, 2014		Dec. 31, 2013		Dec. 31, 2012
Revenue	$ 0		$ 0		$ 0
Operating expense
Research and development	1,630,439	[1]	1,518,885	[1]	1,132,712	[1]
General and administrative	2,715,146	[2]	1,634,650	[2]	986,097	[2]
Total operating expense	4,542,246		3,269,240		2,582,679
Net operating loss	(4,542,246)		(3,269,240)		(2,582,679)
Other income (expense)
Interest income	22,632		4,037		779
Other expense	(335)		(810)		(637)
Total Other Income (Expense)	22,297		3,227		142
Net Loss Before Income Taxes	(4,519,949)		(3,266,013)		(2,582,537)
Income tax expense	0		0		0
Net Loss	(4,519,949)		(3,266,013)		(2,582,537)
Loss per share
Net loss per share, basic and diluted	$ (0.05)		$ (0.05)		$ (0.04)
Basic and diluted weighted average number of common shares outstanding	89,281,622		71,372,672		59,317,779
Related Party
Operating expense
Research and development	$ 196,661	[3]	$ 115,705	[3]	$ 463,870	[3]

[1] Research and development expense includes stock option expense of $83,139, $32,879 and $53,645 for the years ending 12/31/2014, 12/31/2013 and 12/31/2012, respectively. Research and development expense also includes amortization expense of $160,625 for the years ending 12/31/2014 and 12/31/2013, and $185,271 for the year ending 12/31/2012.

[2] General & administrative expense includes stock option expense of $321,011, $671,601 and $9,740 for the years ending 12/31/2014, 12/31/2013 and 12/31/2012, respectively. General & administrative expense also includes depreciation expense of $10,284 for the year ended 12/31/2014.

[3] Includes $345,000 technology impairment charge for the year ending 12/31/2012.